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1  | INTRODUC TION
It is well known that during the progression from periodon-
tal health to disease, the oral microbiota changes.1,2 These 
changes, called dysbiosis, are reflected by increased numbers of 
pathobionts, natural members of the human microbiota that can 
cause pathology and reduce the proportion of commensal bacte-
ria.3-5 Pathobionts appear to dysregulate the host inflammatory 
response, which can lead to chronic inflammation.3,5 Recently, it 
was shown that certain species of commensal bacteria suppress 
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Background and Objective: Little is known about the initiation of dysbiosis in oral 
biofilms, a topic of prime importance for understanding the etiology of, and prevent-
ing, periodontitis. The aim of this study was to evaluate the effect of different con-
centrations of crevicular and salivary peroxidase and catalase on dysbiosis in 
multispecies biofilms in vitro.
Material and Methods: The spotting technique was used to identify the effect of dif-
ferent concentrations of myeloperoxidase, lactoperoxidase, erythrocyte catalase, 
and horseradish peroxidase in salivary and crevicular fluid on the inhibitory effect of 
commensals on pathobiont growth. Vitality–quantitative real- time PCR was per-
formed to quantify the dysbiotic effect of the peroxidases (adjusted to concentra-
tions found in periodontal health, gingivitis, and periodontitis) on multispecies 
microbial communities.
Results: Agar plate and multispecies ecology experiments showed that production of 
hydrogen peroxide (H2O2) by commensal bacteria decreases pathobiont growth and 
colonization. Peroxidases at concentrations found in crevicular fluid and saliva neu-
tralized this inhibitory effect. In multispecies communities, myeloperoxidase, at the 
crevicular fluid concentrations found in periodontitis, resulted in a 1- 3 Log increase in 
pathobionts when compared with the crevicular fluid concentrations found in perio-
dontal health. The effect of salivary lactoperoxidase and salivary myeloperoxidase 
concentrations was, in general, similar to the effect of crevicular myeloperoxidase 
concentrations.
Conclusions: Commensal species suppress pathobionts by producing H2O2. Catalase 
and peroxidases, at clinically relevant concentrations, can neutralize this effect and 
thereby can contribute to dysbiosis by allowing the outgrowth of pathobionts.
K E Y W O R D S
gingival crevicular fluid, in vitro model, inflammation, periodontal disease, periodontal 
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the outgrowth of periodontal pathobionts by producing hydro-
gen peroxide (H2O2).
6,7 However, human serum, horseradish per-
oxidase, and blood components can neutralize this suppressive 
effect, leading to dysbiosis.7 The underlying mechanism may be 
mediated by catalase and peroxidases, enzymes that are gen-
erally considered to be protective to the host because they can 
protect cells from reactive oxygen species (catalase) or produce 
antibacterial products such as hypothiocyanite (lactoperoxidase) 
or hypochlorous acid (myeloperoxidase).8-10 Other studies indicate 
that myeloperoxidase may be the best biomarker for site- specific 
diagnosis of periodontitis11 and that its levels decrease in gingi-
val crevicular fluid after periodontal therapy.12 Myeloperoxidase 
is present in saliva and gingival crevicular fluid, but its relation-
ship to the development of dysbiosis has not been examined. 
Unlike myeloperoxidase, lactoperoxidase is mostly present in 
saliva, whereas myeloperoxidase is found in polymorphonuclear 
leukocytes, which migrate into the oral cavity at gingival crev-
ices.13 Lactoperoxidase should therefore enhance the presence of 
pathobionts in healthy saliva so that they are available to promote 
dysbiosis in the sulcus. Catalase is a third peroxidase and it con-
verts H2O2 to water. It appears in the gingival sulcus of pockets 
whenever bleeding occurs. Bleeding of the gingiva is provoked by 
brushing or probing and it indicates gingival inflammation and po-
tential periodontal instability.14 Erythrocytes present in a sulcus 
or pocket at sites exhibiting periodontitis are exposed to bacterial 
hemolysins15 and such erythrocytes release catalases16,  which are 
reported to initiate dysbiosis in oral biofilms.7 In summary, it has 
been shown that commensal bacteria can suppress the overgrowth 
of pathobionts by producing H2O2.
6 High concentrations of cata-
lytic molecules, such as horseradish peroxidase, remove H2O2 and 
cause dysbiosis.7 Current evidence indicates that the concentra-
tions of myeloperoxidase in the gingival sulcus in health, gingivitis, 
and periodontitis are related to periodontal disease severity.11,17,18
The aim of this study was to determine the concentrations of 
peroxidase in saliva or gingival crevicular fluid, when oral hygiene is 
insufficient (as in gingivitis or periodontitis), that are able to remove 
H2O2 and thus contribute to dysbiosis in multispecies biofilms in vitro.
As Leppilahti and coworkers only stated the range of myelop-
eroxidase concentrations used in their study,11 the authors were 
contacted and asked to provide the average concentrations of my-
eloperoxidase and catalase used.  Lactoperoxidase and myeloperoxi-
dase were also used at concentrations found in saliva.13 The bacteria 
selected for use in this study were chosen by screening the scientific 
literature for oral commensal bacteria with a high prevalence and 
association with periodontal health, a low prevalence in periodontal 
disease, and/or a known inhibitory activity against oral pathogens 
(Streptococcus sanguinis, Streptococcus cristatus, Streptococcus ora-
lis, Streptococcus parasanguinis, Streptococcus gordonii, Streptococcus 
mitis, Streptococcus salivarius, Actinomyces viscosus, Actinomyces 
naeslundii, and Veillonella parvula).1,2,6 By contrast, Fusobacterium 
nucleatum, Porphyromonas gingivalis, Aggregatibacter actinomycetem-
comitans, and Prevotella intermedia are well known for their involve-
ment and prevalence in periodontal diseases,1,2,6 and Streptococcus 
mutans and Streptococcus sobrinus are known for their involvement 
in tooth decay.19,20
2  | MATERIAL AND METHODS
2.1 | Bacteria and media
The following bacteria were used as commensal species in this study: S. 
sanguinis LM14657, S. cristatus ATCC 49999, S. gordonii ATCC 49818, S. 
parasanguinis DSM 6778, S. mitis DSM 12643, S. oralis DSM 20627, S. 
salivarius TOVE- R, A. viscosus DSM 43327, A. naeslundii ATCC 51655, 
and V. parvula DSM 2008. Streptococcus mutans ATCC 20523, S. sobrinus 
ATCC 20742, P. intermedia ATCC 25611, P. gingivalis ATCC 33277, F. nu-
cleatum ATCC 20482, and A. actinomycetemcomitans ATCC 43718 were 
used as pathobionts. All bacteria were maintained on blood agar (Oxoid, 
Basingstoke, UK) supplemented with 5 mg/mL of hemin (Sigma, St Louis, 
MO, USA), 1 mg/mL of menadione (Calbiochem- Novabiochem, La Jolla, 
CA, USA) and 5% sterile horse blood (E&O Laboratories, Bonnybridge, 
UK). Overnight liquid cultures were prepared in Brain- Heart Infusion 
(BHI) broth (Difco, Detroit, MI, USA). Competitive inhibition experi-
ments were performed in Brain Heart Infusion- 2 (BHI- 2) broth or agar 
containing Brain Heart Infusion medium (Difco) supplemented with 
2.5 g/L of mucin (Sigma- Aldrich, St Louis, MO, USA), 1.0 g/L of yeast 
extract (Oxoid), 0.1 g/L of cysteine (Calbiochem, San Diego, CA, USA), 
2.0 g/L of sodium bicarbonate and 0.25% (v/v) glutamic acid (Sigma- 
Aldrich). The bacteria were cultured under aerobic (5% CO2) or an-
aerobic (80% N2, 10% H2, and 10% CO2) conditions. Optical densities 
(ODs) were measured and adjusted using spectrophotometry at an OD 
of 600nm (GeneQuant 100 Spectrophotometer; GE Healthcare, Bucks, 
UK). To verify the effect of myeloperoxidase, lactoperoxidase, catalase, 
and horseradish peroxidase on the antimicrobial effect of commensal 
bacteria, the effect of these enzymes on the growth of the pathobionts 
on agar plates and in complex 14- species communities was evaluated.
2.2 | Peroxidases
Myeloperoxidase from human leukocytes (Sigma- Aldrich) was dis-
solved in BHI- 2 at concentrations of 8.91 ng/mL, 53.12 ng/mL, 
and 1.18 μg/mL, corresponding to the clinical concentrations of 
 myeloperoxidase found in human gingival crevicular fluid from peri-
odontally healthy patients, patients with gingivitis, and patients with 
periodontitis, respectively.11 Catalase (from human erythrocytes) and 
horseradish peroxidase (Sigma- Aldrich) were also dissolved in BHI- 2 
at the same concentrations as myeloperoxidase.11 Lactoperoxidase 
(Sigma- Aldrich) from bovine milk (equal in activity to salivary peroxi-
dase) and myeloperoxidase were adjusted to the salivary concentra-
tions of 1.90 μg/mL and 3.60 μg/mL, respectively, in BHI- 2.13
2.3 | Inhibitory experiments on agar plates
In brief, 7 μL of an overnight culture of a commensal species was 
spotted onto an agar plate and incubated for 24 hours in aerobic 
conditions, as described by Herrero et al.6,7 Afterwards, 7 μL of the 
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peroxidase solution was spotted next to spots of the commensal spe-
cies and left to dry for 5 minutes at 37°C under aerobic conditions. 
Afterwards, 7 μL of an overnight pathobiont culture was spotted on 
top of the peroxidase spots and at the opposite side of the commen-
sal spot, as a control. Afterwards, the agar plates were incubated 
under anaerobic conditions (Figure S1). After 48 hours of anaerobic 
incubation, a calibrated photograph was taken of the agar plate. The 
magnitude of inhibition was measured from the edge of the com-
mensal colony to the border of the inhibited pathogen colony using 
ImageJ (http://rsb.info.nih.gov/ij/download.html) (Figure S1).6,7
2.4 | Biofilm experiments
Overnight cultures of 6 H2O2- producing species of commensal bac-
teria (S. oralis, S. gordonii, S. cristatus, S. parasanguinis, S. mitis, and S. 
sanguinis),6,7 were centrifuged and each pellet was resuspended in 
BHI- 2 broth (adjusted to an OD600 0.5 representing 1 × 10
8 colony- 
forming units [CFUs]/mL). Equal volumes of these solutions were 
mixed together and 1 mL of the mix was inoculated into each of 6 wells 
of a 24-well plate which was then incubated under aerobic conditions. 
After 24 hours, 500 μL of BHI-2 was added to 1 well, myeloperoxidase, 
catalase, and horseradish peroxidase, each adjusted to a crevicular 
fluid concentration of 8.91 ng/mL (periodontally healthy), 53.12 ng/
mL (gingivitis), and 1.18 μg/mL (periodontitis), were added to a further 
3 wells, myeloperoxidase adjusted to a salivary concentration of 3.60 
μg/mL was added to 1 well, and lactoperoxidase adjusted to a salivary 
concentration of 1.90 μg/mL, was added to 1 well. Additionally, 1 mL of 
a bioreactor (OD600	0.5		̴1	×	10
8 CFU/mL)- derived complex multispe-
cies co- culture of 14 species (containing, mean[SD], 7.40[0.61] Log10 
genome equivalents [Geq]/mL of A. actinomycetemcomitans, 8.09[1.47] 
Log10 Geq/mL of F. nucleatum, 8.08[0.26] Log10 Geq/mL of P. gingi-
valis, 7.01[0.23] Log10 Geq/mL of P. intermedia, 6.62[0.92] Log10 Geq/
mL of S. mutans, 7.21[0.52] Log10 Geq/mL of S. sobrinus, 6.54[0.31] 
Log10 Geq/mL of A. naeslundii, 7.45[0.23] Log10 Geq/mL of S. gordonii, 
6.43[0.20] Log10 Geq/mL of A. viscosus, 5.72[1.05] Log10 Geq/mL of S. 
salivarius, 5.16[0.97] Log10 Geq/mL of S. mitis, 6.80[0.40] Log10 Geq/
mL of S. sanguinis, 5.75[0.45] Log10 Geq/mL of S. oralis, and 8.74[0.49] 
Log10 Geq/mL of V. parvula) was centrifuged (1438 g, 10 min-
utes), resuspended in BHI- 2 (adjusted to an OD600 0.5 representing 
1 × 108 CFU/mL), and added to each well. After 24 hours of anaerobic 
incubation, 1 mL was removed from each well and analyzed using vi-
tality qPCR. Afterwards, the remaining supernatant was removed and 
the biofilms at the bottom of the wells were washed with phosphate- 
buffered saline. The biofilms were detached by incubation with 500 μL 
of 0.05% Trypsin- EDTA (Gibco, Paisley, UK) for 15 minutes at 37°C, 
transferred to Eppendorf tubes, centrifuged (6010 g, 10 minutes) and, 
after discarding the trypsin, the biofilm pellets were resuspended in 
1 mL of phosphate- buffered saline and analyzed using vitality qPCR.
2.5 | Bioreactor- derived multispecies community
A multispecies community was established in a BIOSTAT B TWIN 
(Sartorius, Göttingen, Germany) bioreactor. In brief, 750 mL of BHI- 2 
broth was added to the vessel together with 5.0 mg/mL of hemin, 
1.0 mg/mL of menadione, and 200 μL/L of Antifoam Y- 30 (Sigma- 
Aldrich). The medium was pre- reduced over 24 hours at 37°C by bub-
bling 100% N2 and 5% CO2 through the medium under continuous 
stirring at 300 rpm. The pH was set to pH 6.7 ± 0.1. After 24 hours, 
overnight cultures of S. sanguinis, S. gordonii, S. salivarius, S. mitis, S. ora-
lis, S. mutans, S. sobrinus, A. viscosus, A. naeslundii, P. intermedia, P. gin-
givalis, F. nucleatum, A. actinomycetemcomitans, and V. parvula were 
adjusted to an OD of 1.4 and 750µl of each culture was added to the 
bioreactor. During the first 48 hours, the medium was not replaced. 
Thereafter, the medium was replaced at a rate of 200 mL/24 hours.
2.6 | Vitality qPCR
DNA extraction and vitality qPCR with propidium monoazide (Biotium 
Inc., Hayward, CA, USA) was performed.21 Propidium monoazide was 
dissolved in 20% dimethylsulfoxide to produce stock concentrations 
of	1	mg/mL.	These	were	stored	at	−20°C	in	the	dark.	Ten	microlitres	
of propidium monoazide stock solution was added to 90-μL culture 
aliquots to achieve a final concentration of propidium monoazide of 
100 μg/mL. Following a 5- min incubation in the dark, samples were 
exposed for 10 minutes to a 650 W halogen light source placed 20 cm 
above the samples. The samples were kept on ice during this period. 
DNA was extracted from bacterial samples using a QIAamp DNA 
Mini kit (Qiagen Ltd., Hilden, Germany) in accordance with the manu-
facturer’s instructions. A qPCR assay was performed using a CFX96 
Real-	Time	System	(BioRad,	Hercules,	CA,	USA).	The	TaqMan	5′	nucle-
ase assay PCR method was used for detection and quantification of 
bacterial DNA. Primer and probe sequences are as described in Table 
S1.7 TaqMan reactions contained 12.5 μL of Mastermix (Eurogentec, 
Seraing, Belgium), 4.5 μL of sterile H2O, 1 μL of each primer and probe, 
and 5 μL of template DNA. Primers and probes were used at different 
concentrations depending on the organism. Assay conditions for all 
primer/probe sets consisted of an initial 2 minutes at 50°C, denatura-
tion for 10 minutes at 95°C, followed by 45 cycles of 95°C for 15 sec-
onds and 60°C for 60 seconds. The bacterial counts are expressed as 
Geq/mL because the concentration was calculated based on plasmid 
standard curves.21
2.7 | Statistical analysis
The data from agar- plate inhibition experiments were compared for 
each combination of compound, species, and pathogen. For each com-
bination of compound, species, and pathogen, a comparison was made 
between inhibition in the presence of the compound and inhibition in 
the absence of the compound. As such, the analysis existed, each time, 
of a comparison between two groups (presence and absence of the 
compound). Five different types of inhibition data existed: 
I  one group showed no growth and the other group showed no in-
hibition. No statistical analysis was performed.
II  one group showed no growth and the other group showed some 
growth. A one-sided t-test was applied to test whether the group 
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with some growth was significantly different from the group with 
no growth.
III  one group showed no inhibition at all and the other group showed 
some growth. A one-sided t-test was applied to test whether the 
group with some growth was significantly lower than the distance 
for no inhibition at all.
IV  both groups showed some inhibition. A paired t-test was applied 
to compare the groups.
V  both groups showed some inhibition and at least one observation 
showed no inhibition at all.
A frailty model, with run as random factor, was fit to compare the 
groups and to take into account the censored character of the data 
that reflected no inhibition at all. P- values were corrected for simul-
taneous hypothesis testing according to Šidák in order to obtain a 
global significance level of 95% for all the comparisons made for a 
specific compound.
For every combination of enzyme, sample type, and species from 
planktonic and biofilm data, a linear mixed model was fit with com-
pound as fixed factor and the log- transformed CFU count as dependent 
variable. The run was modeled as a random factor. A weighing inversely 
proportional to the observed variance of each compound was applied. 
A normal quantile plot showed that the data were normally distributed. 
Compounds were compared with the control and a correction for simul-
taneous hypothesis testing was applied according to Dunnett when one 
control was used and according to Šidák when two controls were used.
3  | RESULTS
3.1 | Decrease of the inhibitory effect of 
commensals on agar plates
All three peroxidases lowered the inhibitory effects of most of the 
commensal bacteria on most of the pathobionts but this was more 
TABLE  1 Effect of the addition of myeloperoxidase (MPO), lactoperoxidase (LPO), catalase, and horseradish peroxidase (HRP) to BHI- 2 
agar on the antagonistic activity of commensal species of bacteria
Bacterial species
MPO LPO Catalase HRP
− + − + − + − +
S. oralis
Aa 1.85 ± 0.03 1.64 ± 0.02 1.52 ± 0.01 0.00 ± 0.00* 1.56 ± 0.02 0.00 ± 0.00* 3.12 ± 0.03 0.53 ± 0.07*
Pi TI 1.19 ± 0.02* TI 0.00 ± 0.00* TI 0.00 ± 0.00* TI 0.00 ± 0.00*
Pg 4.54 ± 0.34 2.14 ± 0.18* TI 0.00 ± 0.00* 2.36 ± 0.06 0.00 ± 0.00* 2.39 ± 0.10 0.00 ± 0.00*
S. sanguinis
Aa 2.79 ± 0.04 2.57 ± 0.04 2.05 ± 0.14 0.53 ± 0.04 1.51 ± 0.07 0.00 ± 0.00* 2.74 ± 0.10 0.97 ± 0.12*
Pi TI 2.10 ± 0.12* TI 0.00 ± 0.00* TI 0.00 ± 0.00* TI 0.00 ± 0.00*
Pg 2.69 ± 0.07 1.30 ± 0.03* 2.44 ± 0.21 0.00 ± 0.00* 3.27 ± 0.06 0.00 ± 0.00* 2.99 ± 0.08 0.00 ± 0.00*
S. parasanguinis
Aa 2.11 ± 0.04 1.36 ± 0.08 1.53 ± 0.06 0.64 ± 0.05* 1.10 ± 0.03 0.00 ± 0.00* 2.06 ± 0.20 0.55 ± 0.18*
Pi TI 0.52 ± 0.05* TI 0.00 ± 0.00* TI 0.00 ± 0.00* TI 0.00 ± 0.00*
Pg 1.92 ± 0.05 1.52 ± 0.01 1.81 ± 0.20 0.00 ± 0.00* 1.94 ± 0.09 0.00 ± 0.00* 1.76 ± 0.05 0.00 ± 0.00*
S. mitis
Aa TI 5.00 ± 0.07* 4.35 ± 0.28 1.08 ± 0.13* TI 0.19 ± 0.04* TI 1.82 ± 0.03*
Pi TI TI TI 0.95 ± 0.08* TI 0.00 ± 0.00* TI 0.78 ± 0.10*
Pg TI 4.23 ± 0.08 TI 0.00 ± 0.00* TI 0.00 ± 0.00* TI 0.00 ± 0.00*
S. gordonii
Aa TI 4.36 ± 0.05* 5.30 ± 0.15 1.63 ± 0.04* 1.78 ± 0.06 0.00 ± 0.00* 5.32 ± 0.38 1.69 ± 0.05*
Pi TI 3.81 ± 0.07* TI 0.38 ± 0.07* TI 0.00 ± 0.00* TI 0.00 ± 0.00*
Pg TI 3.88 ± 0.08* 3.31 ± 0.22 0.00 ± 0.00* 3.90 ± 0.12 0.00 ± 0.00* 4.22 ± 0.23 0.00 ± 0.00*
S. cristatus
Aa 3.16 ± 0.05 2.82 ± 0.02 2.53 ± 0.05 0.72 ± 0.01* 1.32 ± 0.03 0.00 ± 0.00* 2.65 ± 0.11 0.63 ± 0.07*
Pi TI 2.67 ± 0.07* TI 0.00 ± 0.00* TI 0.00 ± 0.00* TI 0.00 ± 0.00*
Pg 3.44 ± 0.24 1.99 ± 0.52 3.42 ± 0.11 2.66 ± 0.06 2.20 ± 0.02 0.00 ± 0.00* 2.23 ± 0.26 0.00 ± 0.00*
Data are given as mean ± SD (n = 3) and represent the zone of inhibition, in mm, against A. actinomycetemcomitans (Aa), P. intermedia (Pi), and P. gingivalis 
(Pg).
*Statistically significant decrease of the inhibitory effect of the commensal bacteria by MPO, LPO, catalase, and HRP (P < .05).
−,	without	addition;	+,	with	addition;	0.00,	no	inhibition;	TI,	total	inhibition.
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pronounced for P. intermedia and P. gingivalis than for A. actinomy-
cemcomitans (Table 1 and Figure S1).
3.2 | Outgrowth of pathobionts in multispecies 
ecologies exposed to the different concentrations of 
peroxidase found in crevicular fluid
The reduction, observed above, of the inhibitory effect of commen-
sal bacteria by myeloperoxidase, catalase, and horseradish peroxi-
dase at concentrations found in the crevicular fluid of patients with 
periodontitis was verified in complex multispecies ecologies. The 
concentrations of myeloperoxidase, catalase, and horseradish per-
oxidase used in these experiments were 8.91 ng/mL, 53.12 ng/mL, 
and 1.18 μg/mL, representing gingival health, gingivitis, and peri-
odontitis, respectively.11
The commensal biofilm significantly inhibited the planktonic and 
biofilm concentrations of P. gingivalis and P. intermedia in a complex 
multispecies ecology model composed of 14 oral species (Figure 1). 
The inhibitory effect on A. actinomycetemcomitans and F. nucleatum 
concentrations was limited, without reaching statistical significance 
(Table 2, Table S2 and S3). In general, myeloperoxidase, catalase, and 
horseradish peroxidase lowered the inhibitory effect of the commensal 
biofilm on planktonic and biofilm concentrations of the periopathobi-
onts. A positive, dose- dependent neutralization effect of myeloper-
oxidase, catalase, and horseradish peroxidase on the inhibitory effect 
of commensal bacteria was observed (Figure 1). The concentrations 
of myeloperoxidase, catalase, and horseradish peroxidase found in 
crevicular fluid of patients with periodontitis showed the strongest 
neutralizing effect on the inhibitory effect of commensal bacteria. At 
concentrations found in gingivitis or in periodontal health, these en-
zymes had weaker neutralizing effects (Figure 1, Table 2, Table S2 and 
S3).
The crevicular fluid concentrations of myeloperoxidase, cat-
alase, and horseradish peroxidase found in patients with peri-
odontitis resulted, respectively, in an outgrowth of P. gingivalis of, 
on average, 1.31(0.28), 3.25(0.07), and 2.89(0.43) Log10 Geq/mL 
in complex planktonic multispecies ecologies (Figure 1A) and of 
1.44(0.02), 2.89(0.27), and 3.76(0.01) Log10 Geq/mL in complex 
multispecies biofilms (Figure 1B), all values given as mean(SD). 
For P. intermedia, the outgrowth was, on average, 2.84(0.24), 
2.97(0.04), and 2.92(0.01) Log10 Geq/mL in planktonic multispe-
cies ecologies (Figure 1C) and 3.16(0.19), 3.23(0.05), and 3.14(0.18) 
Log10 Geq/mL in complex multispecies biofilms (Figure 1D). The 
outgrowth was pronounced most when the enzymes were used at 
concentrations found in periodontitis. However, there was a clear 
concentration- dependent effect observed when using enzyme 
concentrations found in periodontal health vs enzyme concen-
trations found in gingivitis or vs enzyme concentrations found in 
periodontitis (Figure 1).
The outgrowth of P. gingivalis and P. intermedia was also signifi-
cantly higher when enzyme concentrations found in periodontitis 
were compared with enzyme concentrations found in periodontal 
health (Figure 1). The difference in myeloperoxidase concentra-
tion between periodontal health and periodontitis resulted in an 
F IGURE  1 Neutralization effect of myeloperoxidase (MPO), catalase (CT), and horseradish peroxidase (HRP) on complex multispecies 
biofilms. Control refers to a 14- species community without addition of the 6 species of commensal bacteria and BHI refers to an 
experimental condition without peroxidases. (A, B) Concentration of Porphyromonas gingivalis (Pg) after exposure to MPO, CT, and HRP, in 
planktonic and biofilm conditions. (C, D) Concentration of Prevotella intermedia (Pi) after exposure to MPO, CT, and HRP, in planktonic and 
biofilm conditions. Data are expressed as mean ± SD (n = 3) Log10 genome equivalents (Geq)/mL. *Statistically significant difference of the 
bacterial concentration in comparison with BHI (P < .05). #Statistically significant difference of the bacterial concentration in comparison 
with that in periodontal health
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outgrowth of P. gingivalis of 1.21(0.33) Log10 Geq/mL in planktonic 
conditions and of 1.05(0.09) Log10 Geq/mL in biofilms (Figure 1A,B). 
The outgrowth of P. intermedia was 2.84(0.24) Log10 Geq/mL in plank-
tonic cultures and 3.16(0.19) Log10 Geq/mL in biofilms (Figure 1C,D) 
when comparing enzyme concentrations found in periodontal health 
with enzyme concentrations found in periodontitis. For catalase and 
horseradish peroxidase, no concentration- dependent effect was ob-
served. Catalase and horseradish peroxidase resulted in a P. gingivalis 
outgrowth of 2- 3 Log10 Geq/mL in multispecies biofilms (Figure 1).
Myeloperoxidase, catalase, and horseradish peroxidase also af-
fected the growth of the other species in the community (Table 2, 
Tables S2 and S3). The presence of myeloperoxidase at a concen-
tration found in gingivitis or periodontitis resulted in a significant 
increase in the planktonic growth of A. actinomycetemcomitans, A. 
viscosus, S. sobrinus, S. gordonii, S. oralis, S. salivarius, or V. parvula 
when compared with the levels of these species found after exposure 
to myeloperoxidase levels found in periodontal health. In biofilms, 
the presence of myeloperoxidase at concentrations found in gingi-
vitis or periodontitis significantly increased the growth of V. parvula. 
Conversely, the presence of catalase and horseradish peroxidase at 
concentrations found in periodontal health significantly reduced the 
growth of S. mutans, S. oralis, and S. gordonii compared with the BHI 
control in planktonic ecologies. At concentrations found in gingivitis 
and periodontitis, catalase significantly decreased the growth of S. 
mutans, S. sobrinus, and A. viscosus compared with the BHI control 
in biofilm ecologies. Similarly, the presence of catalase at crevicu-
lar fluid concentrations found in health, gingivitis, and periodonti-
tis reduced the numbers of S. sobrinus in the biofilms. Additionally, 
the growth of S. mutans was reduced when catalase concentrations 
found in gingivitis and periodontitis were used, and the growth of 
A. viscosus was reduced when catalase concentrations found in gin-
givitis were used. The presence of horseradish peroxidase did not 
decrease the abundance of any of the bacterial species present in 
the biofilm. Rather, horseradish peroxidase stimulated an increase 
in the numbers of S. gordonii when used at concentrations found in 
periodontal health and gingivitis and an increase in the numbers of 
A. naeslundii and A. viscosus at when used at concentrations found in 
periodontitis, compared with the BHI control.
3.3 | Outgrowth of pathobionts in multispecies 
ecologies following exposure to the concentrations of 
lactoperoxidase and myeloperoxidase found in saliva
The effect of salivary concentrations of lactoperoxidase and myeloper-
oxidase on periopathobionts was investigated in multispecies ecologies 
(Table 3). Salivary concentrations of lactoperoxidase and myeloperoxi-
dase resulted in outgrowth of P. gingivalis of, on average, 1.00(0.23) 
and 1.14(0.18) Log10 Geq/mL, respectively, in planktonic (Figure 2A) 
and of, on average, 1.29(0.15) and 1.50(0.11) Log10 Geq/mL, respec-
tively, in biofilms (Figure 2B). In addition, salivary concentrations of lac-
toperoxidase and myeloperoxidase also resulted in an outgrowth of P. 
intermedia of 0.95(0.23) and 1.06(0.26) Log10 Geq/mL, respectively, in 
planktonic biofilms (Figure 2A) and of 1.23(0.23) and 1.28(0.11) Log10 
Geq/mL, respectively, in multispecies biofilms (Figure 2B). In general, 
the effect of myeloperoxidase was slightly stronger than the effect of 
lactoperoxidase.
The presence of salivary concentrations of lactoperoxidase and 
myeloperoxidase resulted also in an effect on the growth of differ-
ent species of the community (Table 3). The presence of lactoper-
oxidase reduced significantly the planktonic growth of A. naeslundii 
and A. viscosus and the growth of S. sobrinus and S. oralis in biofilms. 
The presence of myeloperoxidase stimulated increased growth of A. 
actinomycetemcomitans and S. mutans in biofilms.
4  | DISCUSSION
One should consider that little is known about the initiation of dys-
biosis in periodontal diseases,3,5 which is obviously of prime impor-
tance for understanding its etiology and preventing periodontitis. 
Recently it has been shown that some commensal bacteria inhibit 
the outgrowth of pathobionts by H2O2 production.
6,7 The produc-
tion of H2O2 is, in essence, not restricted to commensal, albeit bene-
ficial, bacteria. For instance, Streptococcus pneumoniae, a common 
pathogen of the upper respiratory tract, can inhibit the growth of 
Haemophilus influenza by producing H2O2.
22 However, H2O2 pro-
duction has never been described in periodontopathogens. None of 
the species used in this study produced H2O2 except for S. oralis, 
S. gordonii, S. cristatus, S. parasanguinis, S. mitis, and S. sanguinis.6,7 
Serum, high concentrations of horseradish peroxidase, and certain 
blood compounds can neutralize the inhibitory effect of H2O2 in 
multispecies biofilms, which results in dysbiosis.7 The data from the 
current study show that, in vitro, clinically relevant peroxidases and 
catalase at  clinically relevant peroxidases (myeloperoxidase, lac-
toperoxidase) and catalase, when used at clinically relevant concen-
trations (i.e. as found in gingivitis and periodontitis) can neutralize 
the inhibitory effect of commensal bacteria on pathobiont growth 
on agar plates, in planktonic cultures, and in multispecies biofilms. 
Moreover, increasing the concentration of myeloperoxidase from 
that found in gingival crevicular fluid of periodontally healthy pa-
tients to that found in patients with periodontitis resulted in a 1- 3 
Log10 Geq/mL increase in pathobionts. These in vitro data might 
explain the correlation between periodontitis and myeloperoxidase 
concentrations and suggest that the concentration of myeloperoxi-
dase found in gingival crevicular fluid can contribute to the dysbio-
sis seen in subgingival plaque of patients with periodontal disease. 
In concordance with these data, previous studies have shown that 
the addition of peroxidases could neutralize the inhibitory effect 
of commensal bacteria on agar plates and multispecies communi-
ties.6,7,23,24 However, the concentrations of peroxidases used in 
these studies were not clinically relevant. The results indicate that 
an increase  in clinically relevant peroxidase concentrations causes 
the outgrowth of pathobionts, such as P. gingivalis, A. actinomycet-
emcomitans, and P. intermedia. The factors that influence the con-
centrations and activity of myeloperoxidase or lactoperoxidase are 
not well known. However, A. actinomycetemcomitans can increase 
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significantly the release of myeloperoxidase by neutrophils,25 which 
may enhance the dysbiosis observed in periodontal diseases. For 
other pathobionts, such an effect has not yet been investigated. 
However, in studies of experimental gingivitis, the concentration of 
myeloperoxidase has been shown to increase after only 4 days.26,27 
Also, in subjects who smoke (smoking is a significant risk factor for 
periodontitis), elevated levels of myeloperoxidase have been found 
in saliva and serum, apparently as a result of stimulation of neutro-
phils by nicotine.28,29 Genetic influences can also affect the activity 
and concentration of oral peroxidases. A clinical study showed an 
association between MPO- 463 gene polymorphisms and aggressive 
periodontitis.30 The myeloperoxidase activity of individuals with the 
MPO- 463GG variant has been reported to be higher than that of 
individuals with the MPO- 463AA variant. The MPO G/G genotype 
has been associated with coronary artery disease, leukemia, can-
cer, multiple sclerosis and higher risk for periodontal disease.31,32 
Interestingly, myeloperoxidase deficiency, a frequently occurring 
genetic disorder which is related to a reduced quantity or function of 
myeloperoxidase, is rarely associated with clinical symptoms unless 
the patient also suffers from diabetes mellitus, which leads to dis-
seminated candidiasis and other fungal infections.33 Until now, not 
even a case report has been published on whether the levels of gin-
givitis or periodontitis are increased in patients with myeloperoxi-
dase deficiency. In this context, it would be interesting to investigate 
F IGURE  2 Neutralization effect of myeloperoxidase (MPO) and lactoperoxidase (LPO) adjusted to salivary concentrations on complex 
multispecies biofilms. Control refers to a 14- species community without the addition of the 6 commensal bacteria, and BHI refers to 
an experimental condition without peroxidases. (A, B) Concentration of Porphyromonas gingivalis (Pg) and Prevotella intermedia (Pi) after 
exposure to lactoperoxidase (LPO) and myeloperoxidase (MPO), in planktonic and biofilm conditions. Data are expressed as mean ± SD 
(n = 3) Log10 genome equivalents (Geq)/mL. *Statistically significant difference of the bacterial concentration in comparison with BHI 
(P < .05)
TABLE  3 Concentrations of the different species of bacteria in the 14- species biofilms that were exposed to salivary concentrations of 
lactoperoxidase (LPO) and myeloperoxidase (MPO) 
Bacterial species
Planktonic Biofilm
Without 
LPO and 
MPO LPO Saliva MPO Saliva Control
Without 
LPO and 
MPO LPO Saliva MPO Saliva Control
Aa 7.44 ± 0.11 7.46 ± 0.06 7.57 ± 0.06 7.76 ± 0.07* 6.61 ± 0.16 6.77 ± 0.12 6.82 ± 0.08* 7.61 ± 0.08*
Pi 5.35 ± 0.37 6.30 ± 0.15* 6.40 ± 0.16* 7.19 ± 0.21* 5.51 ± 0.25 6.75 ± 0.10* 6.79 ± 0.18* 7.84 ± 0.13*
Pg 6.38 ± 0.18 7.38 ± 0.09* 7.51 ± 0.01* 8.32 ± 0.07* 6.24 ± 0.10 7.52 ± 0.11* 7.74 ± 0.01* 8.22 ± 0.11*
Fn 8.98 ± 0.10 8.89 ± 0.04 8.90 ± 0.05 8.93 ± 0.16 9.01 ± 0.04 9.12 ± 0.23 9.12 ± 0.16 9.12 ± 0.12
A. naeslundii 2.98 ± 0.14 2.63 ± 0.07# 2.91 ± 0.15 3.28 ± 0.54 6.37 ± 0.15 6.31 ± 0.37 6.41 ± 0.17 6.57 ± 0.21
A. viscosus 7.23 ± 0.02 7.10 ± 0.04# 7.10 ± 0.09 7.34 ± 0.11 7.98 ± 0.10 8.15 ± 0.29 8.09 ± 0.04 8.21 ± 0.09*
S. mutans 6.02 ± 0.03 5.93 ± 0.06 5.99 ± 0.10 6.00 ± 0.18 6.56 ± 0.04 6.52 ± 0.05 6.66 ± 0.06* 6.62 ± 0.10
S. sobrinus 6.92 ± 0.02 6.86 ± 0.05 6.82 ± 0.13 8.04 ± 0.10* 7.95 ± 0.11 7.67 ± 0.13# 7.69 ± 0.10 9.31 ± 0.11*
S. sanguinis 7.06 ± 0.06 6.99 ± 0.07 7.09 ± 0.08 6.62 ± 0.08# 8.10 ± 0.05 8.13 ± 0.09 8.20 ± 0.07 8.04 ± 0.02#
S. gordonii 9.43 ± 0.07 9.42 ± 0.11 9.47 ± 0.09 9.95 ± 0.11* 10.30 ± 0.09 10.43 ± 0.38 10.42 ± 0.11 10.55 ± 0.14
S. oralis 7.36 ± 0.08 7.29 ± 0.06 7.23 ± 0.19 6.70 ± 0.11# 8.03 ± 0.07 7.87 ± 0.10# 7.97 ± 0.03 7.85 ± 0.24
S. salivarius 3.95 ± 0.47 3.99 ± 0.29 4.21 ± 0.18 5.49 ± 0.16* 4.60 ± 0.21 5.06 ± 0.43 4.73 ± 0.08 5.15 ± 0.46
V. parvula 7.97 ± 0.01 7.96 ± 0.05 7.96 ± 0.09 8.45 ± 0.04* 10.06 ± 0.07 10.05 ± 0.16 10.11 ± 0.03 10.11 ± 0.03
S. mitis 4.93 ± 0.23 4.86 ± 0.12 4.86 ± 0.17 5.02 ± 0.13 5.45 ± 0.13 5.26 ± 0.23 5.58 ± 0.11 5.13 ± 0.25
Values are given as mean ± SD (n = 3) Log10 genome equivalents (Geq)/mL. “Control” refers to a 14- species community without addition of the 6 species 
of commensal bacteria. “Without LPO and MPO” refers to a condition without peroxidases.
*Designates a statistically significant increase of the bacterial concentration in respect to “Without LPO and MPO” (P < .05). #Designates a statistically 
significant decrease of the bacterial concentration in respect to “Without LPO and MPO” (P < .05).
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if patients with myeloperoxidase deficiency are more resistant to 
gingivitis or periodontitis.
Bleeding periodontal pockets are an indicator for periodontal 
diseases.14 Some blood compounds have been shown to induce dys-
biosis in multispecies ecologies.7 Recently, an association between 
bacterially mediated hemolysis and the clinical parameters of peri-
odontitis has been described.15 The catalase released from erythro-
cytes, as a result of the action of bacterial hemolysin, can contribute 
to the dysbiotic effect.16,34 Our results show that catalase from 
erythrocytes decreased the suppressive effect of H2O2 produced by 
commensal bacteria, leading to the outgrowth of pathobionts with 
2- 3 Log10 Geq/mL in oral multispecies biofilms. Similar effects have 
been reported for other blood components with peroxidase activ-
ity, such as serum, hemoglobin, and hemin.7 The neutralization of 
H2O2 by serum, hemoglobin, and hemin increased the colonization 
of P. gingivalis by 3 Log10 Geq/mL in oral multispecies biofilms but 
resulted in a higher outgrowth of P. intermedia and A. actinomycetem-
comitans in multispecies biofilms. These differences in outgrowth 
can be explained by the concentrations of serum, hemoglobin, and 
hemin used in that study, which were higher than the concentrations 
used in the present study.
Saliva also harbors different peroxidases, mainly lactoperoxidase 
and myeloperoxidase.13 The results of our study showed that salivary 
concentrations of lactoperoxidase and myeloperoxidase increased the 
growth of pathobionts by 1- 2 Log10 Geq/mL in multispecies biofilms. 
These data are in line with recent clinical studies, which indicated a 
positive correlation between myeloperoxidase concentrations in saliva 
and clinical signs of gingival or periodontal diseases.35,36
Overall, this study suggests that when dental plaque persists 
over a long period of time because of poor dental hygiene and/or 
when the susceptibility of the host changes, peroxidases resulting 
from the inflammatory response can play an important role in the 
development of dysbiosis of oral biofilms by disrupting the inhibi-
tion of pathobiont growth by commensal bacteria. Plaque accu-
mulation also creates a more anaerobic environment, which limits 
oxygen availability at the base of the sulcus, subsequently lower-
ing H2O2 production and thus contributing to the dysbiotic effect. 
Unfortunately, it is not known when dysbiosis becomes irreversible 
with respect to H2O2 production and no studies are available that 
directly correlate concentrations of oral peroxidase with microbio-
logical data.
One should consider that the 16- species biofilm model does not 
take into account the host–microbiome interactions. This might be of 
importance because myeloperoxidase also promotes the formation 
of neutrophil extracellular traps, which can enhance its antimicrobial 
activity through different mechanisms.37 Additionally, myeloperox-
idase produced by neutrophils can utilize H2O2 to generate hypo-
chlorous acid to kill bacteria.33 The impact of these scenarios was 
not captured in the current model and therefore needs to be vali-
dated in in vivo animal models.
The chronological steps in the initiation of dysbiosis are far from 
being elucidated. To date, it is not clear if an increase in myeloper-
oxidase concentration triggers a shift toward a dysbiotic biofilm or 
if other factors (eg, environmental factors, such as oxygen or pH) 
initiate the occurrence of dysbiotic biofilms, which in turn induce the 
release of higher concentrations of myeloperoxidase. At this point 
the influence and role of these factors in the initiation of dysbiosis 
remains to be investigated in future studies.
In conclusion, under the given experimental conditions, clinically 
relevant peroxidases and catalase can contribute to dysbiosis at clin-
ically relevant concentrations in 16- species in vitro oral biofilms.
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